Profile data is unavailable for this security.
About the company
Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider company. The Company is engaged in research and development, manufacturing, marketing, and distribution of pharmaceutical products. The Company manufactures products across various therapeutic categories, including Pain Management, Cough and Cold, Cardiovascular and Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic, among others. The Company manufactures a range of products, including tablets, capsules, dry syrup, non-beta lactum, ointments, and creams. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Letrozole, Melphalan, Oxaliplatin, Pazopanib, Its Cardiology products include Nifedipine Capsules, Atorvastatin Tablets, Fenofibrate Capsules, Rosuvastatin Tablets.
- Revenue in INR (TTM)1.82bn
- Net income in INR64.80m
- Incorporated1993
- Employees378.00
- LocationMedicamen Biotech Ltd1506, Chiranjiv Tower, 43, Nehru PlaceNEW DELHI 110019IndiaIND
- Phone+91 1 147589500
- Fax+91 1 126213081
- Websitehttps://medicamen.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medico Remedies Ltd | 1.41bn | 76.77m | 3.70bn | 193.00 | 48.74 | 6.67 | 34.83 | 2.62 | 0.9159 | 0.9159 | 16.88 | 6.69 | 1.40 | 6.35 | 2.63 | 7,318,264.00 | 7.63 | 6.15 | 14.54 | 12.40 | 26.19 | 25.26 | 5.44 | 3.99 | 1.40 | 11.24 | 0.1705 | -- | 3.19 | 8.21 | 14.49 | 39.49 | -7.58 | -- |
| Venus Remedies Ltd. | 6.15bn | 221.01m | 3.99bn | 1.19k | 18.04 | 0.8078 | 8.50 | 0.6495 | 16.56 | 16.56 | 461.13 | 369.72 | 0.945 | 2.68 | 8.72 | 5,178,093.00 | 3.40 | 4.82 | 4.06 | 6.17 | 39.06 | 38.90 | 3.60 | 5.58 | 2.69 | 1,660.39 | 0.0765 | -- | 8.27 | 13.32 | 7.25 | -- | 6.38 | -- |
| Kilitch Drugs (India) Ltd | 1.58bn | 164.61m | 4.92bn | 168.00 | 29.78 | 2.60 | 28.38 | 3.12 | 10.28 | 10.28 | 98.44 | 117.72 | 0.6347 | 26.77 | 2.29 | 9,377,369.00 | 5.70 | 3.38 | 7.93 | 4.76 | 34.75 | 35.33 | 8.98 | 6.17 | 2.01 | 2.81 | 0.1467 | 0.00 | 10.58 | 13.35 | 39.75 | 30.69 | -19.45 | -- |
| ZIM Laboratories Ltd | 3.88bn | 161.50m | 5.02bn | 556.00 | 31.14 | 2.07 | 14.80 | 1.29 | 3.31 | 3.31 | 79.19 | 49.82 | 0.9788 | 2.67 | 5.18 | 6,980,632.00 | 4.07 | 3.88 | 5.70 | 6.54 | 53.95 | 47.45 | 4.16 | 3.97 | 0.9475 | 2.77 | 0.3004 | 1.21 | -7.80 | 1.84 | -29.42 | 2.37 | 29.41 | -- |
| Lyka Labs Ltd | 1.32bn | 33.80m | 5.05bn | 423.00 | 153.48 | 5.11 | 40.80 | 3.84 | 0.9226 | 0.9226 | 37.94 | 27.71 | 0.8222 | 6.01 | 3.92 | 3,111,116.00 | 1.95 | -5.48 | 2.50 | -8.30 | 59.65 | 60.82 | 2.38 | -9.16 | 1.23 | 2.34 | 0.2627 | -- | 19.47 | 9.45 | 81.16 | -- | 13.88 | -- |
| Accent Microcell Ltd | 2.62bn | 325.33m | 5.06bn | 174.00 | 12.14 | 2.84 | 14.10 | 1.93 | 19.80 | 19.80 | 141.04 | 84.68 | 1.65 | 4.64 | 6.67 | 15,070,950.00 | 20.43 | -- | 24.77 | -- | 32.30 | -- | 12.41 | -- | 4.81 | -- | 0.0114 | -- | 24.45 | -- | 146.63 | -- | -- | -- |
| Medicamen Biotech Ltd | 1.82bn | 64.80m | 5.49bn | 378.00 | 60.80 | 2.53 | 39.76 | 3.02 | 7.10 | 7.10 | 165.42 | 170.67 | 0.6199 | 1.67 | 2.76 | 4,804,595.00 | 1.99 | 5.89 | 2.76 | 8.45 | 46.53 | 36.54 | 3.22 | 9.58 | 1.41 | 2.67 | 0.0854 | 8.46 | 27.29 | 7.90 | -26.36 | -1.89 | -16.71 | 0.00 |
| IND Swift Laboratories Ltd | 7.26bn | 3.73bn | 6.07bn | 47.00 | 1.62 | 0.600 | 1.52 | 0.836 | 63.24 | 63.24 | 123.25 | 171.20 | 0.486 | 1.73 | 2.54 | 154,462,200.00 | 25.01 | 5.00 | 29.88 | 6.13 | 46.23 | 41.12 | 51.47 | 8.52 | 3.51 | 7.87 | 0.016 | 0.00 | 6.10 | 11.10 | 784.44 | 70.82 | 23.60 | -- |
| Sakar Healthcare Ltd | 1.64bn | 124.03m | 6.20bn | 325.00 | 50.15 | 2.01 | 19.43 | 3.77 | 5.68 | 5.68 | 75.48 | 141.51 | 0.4312 | 3.22 | 7.45 | 5,052,619.00 | 3.25 | 5.26 | 3.85 | 6.28 | 44.83 | 43.47 | 7.55 | 10.12 | 0.6515 | 3.28 | 0.2374 | -- | 14.99 | 17.58 | -8.53 | 11.76 | 19.05 | -- |
| Wanbury Ltd | 5.77bn | 529.62m | 6.99bn | 1.49k | 13.57 | 18.05 | 10.57 | 1.21 | 15.73 | 15.73 | 173.33 | 11.83 | 1.55 | 7.95 | 6.17 | 3,871,231.00 | 14.26 | 11.63 | 39.18 | -- | 49.84 | 42.46 | 9.18 | 7.62 | 0.6908 | 1.71 | 0.8235 | -- | 15.21 | 8.02 | 638.26 | -- | 29.87 | -- |
